aparat aparat telegram1  ar en fa

ساعت کار مرکـز :

شنبه تا 4شنبه: ساعت 8 الی 22 - 5شنبه ها: ساعت 8 الی 14

instagram takipçi satın al indoXploit shell PUBG Lite

متاستاز مغز در سرطان پستان

جدیدترین اطلاعات از متاستاز مغز در بیماران مبتلا به سرطان پستان :

new in breast cancer surgery

Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.
Liu MC, et al. Cancer Metastasis Rev. 2016.
Show full citation
Abstract

Brain metastases are a major cause of morbidity and mortality for women with hormone receptor (HR)-positive breast cancer, yet little is known about the optimal treatment of brain disease in this group of patients. Although these patients are at lower risk for brain metastases relative to those with HER2-positive and triple-negative disease, they comprise the majority of women diagnosed with breast cancer. Surgery and radiation continue to have a role in the treatment of brain metastases, but there is a dearth of effective systemic therapies due to the poor penetrability of many systemic drugs across the blood-brain barrier (BBB). Additionally, patients with brain metastases have long been excluded from clinical trials, and few studies have been conducted to evaluate the safety and effectiveness of systemic therapies specifically for the treatment of HER2-negative breast cancer brain metastases. New approaches are on the horizon, such as nanoparticle-based cytotoxic drugs that have the potential to cross the BBB and provide clinically meaningful benefits to patients with this life-threatening consequence of HR-positive breast cancer.

PMID 27023712 [PubMed - as supplied by publisher]
Citation 1 of 10084
Back to results Next
Similar articles

A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
Review article
Larsen PB, et al. Cancer Treat Rev. 2013.
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Yonemori K, et al. Cancer. 2010.
New target therapies for brain metastases from breast cancer.
Review article
Metro G, et al. Curr Cancer Drug Targets. 2012.
Overview of resistance to systemic therapy in patients with breast cancer.
Review article
Gonzalez-Angulo AM, et al. Adv Exp Med Biol. 2007.
Hormone receptor expression is associated with a unique pattern of metastatic spread and increased survival among HER2-overexpressing breast cancer patients.
Paluch-Shimon S, et al. Am J Clin Oncol. 2009.
See all
Full website NIH NLM NCBI Help

خواندن 1001 دفعه
شنبه, 04 ارديبهشت 1395 15:05 چاپ

نظرات (0)

تاکنون نظری برای این مطلب ارسال نشده است.

نظر خود را اضافه کنید.

در قالب میهمان نظر خود را ارسال کنید. ثبت نام کنید یا وارد شوید به حساب کاربریتان.
0 Characters
پیوست ها (0 / 3)
Share Your Location

اطلاعات مرکز

آدرس: اصفهان - خیابان شمس آبادی-چهارراه قصر-مجتمع قصرنور-طبقه 5-واحد501
تلفن‌های تماس: 32240047-031 - 09130748424
تلفن گویا: 9730361
فکس  : 03132240047
کدپستی: 3165844567
ایمیل: info@novintahlilgaran.com

map

رفتن به بالا